1-methyl-3-isobutylxanthine and peptide phi

1-methyl-3-isobutylxanthine has been researched along with peptide phi in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canavan, JP; Eedy, DJ; Shaw, C; Trimble, ER1
Gardner, JD; Jensen, RT; Jones, SW; Noguchi, M; Villanueva, ML; Zhou, ZC1
Hsueh, AJ; Kasson, BG; Lim, P1
Miledi, R; Woodward, RM1
Wiik, P1
Emami, S; Gespach, C; Prost, A; Rosselin, G1
Heisler, S; Labrie, F; Veilleux, R1

Other Studies

7 other study(ies) available for 1-methyl-3-isobutylxanthine and peptide phi

ArticleYear
Beta-adrenergic stimulation of cyclic AMP is defective in cultured dermal fibroblasts of psoriatic subjects.
    The British journal of dermatology, 1990, Volume: 122, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Adult; Cells, Cultured; Cyclic AMP; Female; Fibroblasts; Humans; Isoproterenol; Male; Peptide PHI; Psoriasis; Skin; Stimulation, Chemical; Vasoactive Intestinal Peptide

1990
Mechanism of action of calcitonin gene-related peptide in stimulating pancreatic enzyme secretion.
    The American journal of physiology, 1986, Volume: 251, Issue:3 Pt 1

    Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Amylases; Animals; Calcitonin Gene-Related Peptide; Cyclic AMP; Guinea Pigs; Male; Nerve Tissue Proteins; Pancreas; Peptide PHI; Peptides; Phosphodiesterase Inhibitors; Secretin; Species Specificity; Theophylline; Vasoactive Intestinal Peptide

1986
Vasoactive intestinal peptide stimulates androgen biosynthesis by cultured neonatal testicular cells.
    Molecular and cellular endocrinology, 1986, Volume: 48, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; 3-Hydroxysteroid Dehydrogenases; Animals; Animals, Newborn; Cell Separation; Cells, Cultured; Cyclic AMP; Glucagon; Luteinizing Hormone; Male; Peptide PHI; Pregnenolone; Progesterone; Rats; Rats, Inbred Strains; Secretin; Testis; Testosterone; Vasoactive Intestinal Peptide

1986
Membrane currents elicited by porcine vasoactive intestinal peptide (VIP) in follicle-enclosed Xenopus oocytes.
    Proceedings of the Royal Society of London. Series B, Biological sciences, 1987, Sep-22, Volume: 231, Issue:1265

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cyclic AMP; Female; In Vitro Techniques; Membrane Potentials; Oocytes; Peptide PHI; Potassium; Receptors, Gastrointestinal Hormone; Receptors, Vasoactive Intestinal Peptide; Swine; Theophylline; Vasoactive Intestinal Peptide; Xenopus laevis

1987
Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism.
    Regulatory peptides, 1989, Volume: 25, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Cells, Cultured; Colforsin; Cyclic AMP; Humans; Monocytes; Oxygen Consumption; Peptide PHI; Secretin; Vasoactive Intestinal Peptide

1989
Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2.
    Bioscience reports, 1984, Volume: 4, Issue:12

    Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cyclic AMP; Humans; Laryngeal Neoplasms; Peptide PHI; Peptides; Receptors, Cell Surface; Receptors, Vasoactive Intestinal Peptide; Vasoactive Intestinal Peptide

1984
PHI stimulates ACTH release from pituitary tumor cell.
    Molecular and cellular endocrinology, 1984, Volume: 35, Issue:2-3

    Topics: 1-Methyl-3-isobutylxanthine; Adrenocorticotropic Hormone; Animals; Calcium; Cell Line; Corticotropin-Releasing Hormone; Cyclic AMP; Dexamethasone; Gastrointestinal Hormones; Mice; Oxotremorine; Peptide PHI; Peptides; Pituitary Neoplasms; Somatostatin

1984